Elecnor, S.A.

BME:ENO Voorraadrapport

Marktkapitalisatie: €1.6b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Elecnor Toekomstige groei

Future criteriumcontroles 0/6

Elecnor's earnings are forecast to decline at 30.1% per annum while its annual revenue is expected to grow at 2.4% per year. EPS is expected to decline by 42.4% per annum. Return on equity is forecast to be 6.9% in 3 years.

Belangrijke informatie

-30.1%

Groei van de winst

-42.4%

Groei van de winst per aandeel

Construction winstgroei5.9%
Inkomstengroei2.4%
Toekomstig rendement op eigen vermogen6.9%
Dekking van analisten

Low

Laatst bijgewerkt23 Sep 2024

Recente toekomstige groei-updates

Recent updates

Elecnor (BME:ENO) Has A Rock Solid Balance Sheet

Sep 18
Elecnor (BME:ENO) Has A Rock Solid Balance Sheet

The Price Is Right For Elecnor, S.A. (BME:ENO)

Aug 23
The Price Is Right For Elecnor, S.A. (BME:ENO)

Is Elecnor, S.A. (BME:ENO) Potentially Undervalued?

Jul 17
Is Elecnor, S.A. (BME:ENO) Potentially Undervalued?

Elecnor's (BME:ENO) Dividend Will Be Increased To €0.3137

May 26
Elecnor's (BME:ENO) Dividend Will Be Increased To €0.3137

These 4 Measures Indicate That Elecnor (BME:ENO) Is Using Debt Reasonably Well

Mar 06
These 4 Measures Indicate That Elecnor (BME:ENO) Is Using Debt Reasonably Well

Is Elecnor, S.A. (BME:ENO) Worth €18.7 Based On Its Intrinsic Value?

Dec 11
Is Elecnor, S.A. (BME:ENO) Worth €18.7 Based On Its Intrinsic Value?

We Think Elecnor (BME:ENO) Is Taking Some Risk With Its Debt

Aug 23
We Think Elecnor (BME:ENO) Is Taking Some Risk With Its Debt

Elecnor (BME:ENO) Has Announced That It Will Be Increasing Its Dividend To €0.292

May 21
Elecnor (BME:ENO) Has Announced That It Will Be Increasing Its Dividend To €0.292

Does Elecnor (BME:ENO) Have A Healthy Balance Sheet?

Sep 24
Does Elecnor (BME:ENO) Have A Healthy Balance Sheet?

Returns Are Gaining Momentum At Elecnor (BME:ENO)

May 19
Returns Are Gaining Momentum At Elecnor (BME:ENO)

Is Elecnor, S.A. (BME:ENO) The Right Choice For A Smart Dividend Investor?

May 01
Is Elecnor, S.A. (BME:ENO) The Right Choice For A Smart Dividend Investor?

Elecnor (BME:ENO) Has A Pretty Healthy Balance Sheet

Mar 16
Elecnor (BME:ENO) Has A Pretty Healthy Balance Sheet

Elecnor (BME:ENO) Shareholders Have Enjoyed A 56% Share Price Gain

Mar 01
Elecnor (BME:ENO) Shareholders Have Enjoyed A 56% Share Price Gain

Returns On Capital At Elecnor (BME:ENO) Paint An Interesting Picture

Feb 11
Returns On Capital At Elecnor (BME:ENO) Paint An Interesting Picture

Elecnor, S.A. (BME:ENO) Vies For A Place In Your Dividend Portfolio: Here's Why

Jan 25
Elecnor, S.A. (BME:ENO) Vies For A Place In Your Dividend Portfolio: Here's Why

Is Elecnor, S.A.'s (BME:ENO) ROE Of 21% Impressive?

Jan 07
Is Elecnor, S.A.'s (BME:ENO) ROE Of 21% Impressive?

What Kind Of Investors Own Most Of Elecnor, S.A. (BME:ENO)?

Dec 18
What Kind Of Investors Own Most Of Elecnor, S.A. (BME:ENO)?

Elecnor (BME:ENO) Could Be A Buy For Its Upcoming Dividend

Dec 02
Elecnor (BME:ENO) Could Be A Buy For Its Upcoming Dividend

Are Insiders Selling Elecnor, S.A. (BME:ENO) Stock?

Nov 30
Are Insiders Selling Elecnor, S.A. (BME:ENO) Stock?

Winst- en omzetgroeiprognoses

BME:ENO - Toekomstschattingen van analisten en financiële gegevens uit het verleden (EUR Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20264,07073-341572
12/31/20254,00172-791352
12/31/20243,959476-41303
6/30/20243,80646174284N/A
3/31/20243,97545N/AN/AN/A
12/31/20233,88263112206N/A
6/30/20233,63338133221N/A
3/31/20233,747105N/AN/AN/A
12/31/20223,42145144227N/A
9/30/20223,56596N/AN/AN/A
6/30/20223,3899245142N/A
3/31/20223,27990N/AN/AN/A
12/31/20213,1338698206N/A
9/30/20212,97383N/AN/AN/A
6/30/20212,8088217206N/A
3/31/20212,53879N/AN/AN/A
12/31/20202,49878-36194N/A
9/30/20202,418125N/AN/AN/A
6/30/20202,41112389259N/A
3/31/20202,465125N/AN/AN/A
12/31/20192,478126109231N/A
9/30/20192,29777N/AN/AN/A
6/30/20192,276845592N/A
3/31/20192,28675N/AN/AN/A
12/31/20182,25682132168N/A
9/30/20182,31873N/AN/AN/A
6/30/20182,3147356174N/A
3/31/20182,32672N/AN/AN/A
12/31/20172,31771N/A43N/A
9/30/20172,27570N/AN/AN/A
6/30/20172,17470N/A81N/A
3/31/20172,09469N/AN/AN/A
12/31/20162,03568N/A198N/A
9/30/20161,93968N/AN/AN/A
6/30/20161,92367N/A216N/A
3/31/20161,90766N/AN/AN/A
12/31/20151,88166N/A237N/A
9/30/20151,88165N/AN/AN/A
6/30/20151,84961N/A204N/A
3/31/20151,74659N/AN/AN/A
12/31/20141,72459N/A-78N/A
9/30/20141,64540N/AN/AN/A
6/30/20141,64134N/A35N/A
3/31/20141,85350N/AN/AN/A
12/31/20131,86453N/A43N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: ENO's earnings are forecast to decline over the next 3 years (-30.1% per year).

Winst versus markt: ENO's earnings are forecast to decline over the next 3 years (-30.1% per year).

Hoge groeiwinsten: ENO's earnings are forecast to decline over the next 3 years.

Omzet versus markt: ENO's revenue (2.4% per year) is forecast to grow slower than the Spanish market (5% per year).

Hoge groei-inkomsten: ENO's revenue (2.4% per year) is forecast to grow slower than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: ENO's Return on Equity is forecast to be low in 3 years time (6.9%).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y